OnKure Therapeutics, Inc. - Class A Common Stock
OnKure Therapeutics, Inc. - Class A Common Stock
Share · US68277Q1058 · OKUR (XNAS)
Overview Financial Indicators
2,87 USD
-5,41 % -0,16 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
11.06.2025 19:59

Current Prices from OnKure Therapeutics, Inc. - Class A Common Stock

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
OKUR
USD
11.06.2025 19:59
2,87 USD
3,00 USD
-4,50 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % -0,17 % 50,00 % -41,83 % -76,67 % -83,23 % -83,23 %

Company Profile for OnKure Therapeutics, Inc. - Class A Common Stock Share

OnKure, Inc. engages in the discovery and development of oncology-precision medicines for the treatment of cancer. The company focuses on developing selective inhibitors of histone deacetylases. Its portfolio includes OKI-179, an inhibitor for the treatment of both hematological and solid tumors. The company was incorporated in 2011 and is based in Boulder, Colorado.

Company Data

Name OnKure Therapeutics, Inc. - Class A Common Stock
Company OnKure Therapeutics, Inc.
Symbol OKUR
Website https://onkuretherapeutics.com
Primary Exchange XNAS NASDAQ
ISIN US68277Q1058
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Nicholas A. Saccomano Ph.D.
Market Capitalization 39 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 6707 Winchester Circle, 80301 Boulder

ID Changes

Date From To
07.10.2024 RPHM OKUR

Ticker Symbols

Name Symbol
NASDAQ OKUR

More Shares

Investors who OnKure Therapeutics, Inc. - Class A Common Stock hold also have the following shares in their portfolio:
ELDORADO GOLD CORP
ELDORADO GOLD CORP Share
GUGGENHEIM ENHANCED EQUITY INCME FUND
GUGGENHEIM ENHANCED EQUITY INCME FUND Fund
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025